London, UK, 02 Dec 2021: Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, today announced it has raised a total of $10.5 million USD (£7.8 million GBP) in its seed funding round. The funding will support the continued development of the Company’s Mergo® RNA therapeutics delivery platform.
Zyme Communications
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Telephone: +44 (0)1223 968 920
Address :
Stirling House, Cambridge Innovation Park, Denny End Road, Waterbeach, Cambridge
Post Code: CB25 9QE
Country: United Kingdom
Website: http://zymecommunications.com
Membership Type: Corporate 6-20
There are no Products & Services to display
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AVA6000. This will allow the Group to expand its Phase I...
29-11-2021
Appointment brings extensive financial industry experience to drive global growth and build corporate value of newly combined organization that is aiming to make the world a healthier, cleaner and better place to live.
17-11-2021
StarBright UltraViolet 400 Dye offers maximal brightness and narrow excitation and emission profiles for precise resolution.
16-11-2021
Investment from Apposite Capital LLP will accelerate CrestOptics’ commercial expansion into new markets globally, and enable further development of innovative cell imaging products.
11-11-2021
SANTA ANA, California, November 10, 2021: FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene...
10-11-2021
San Diego, CA, 10th November 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire LabArchives.
10-11-2021
Ajdovšcina, Slovenia & Bangkok, Thailand, 02 November 2021: BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, today announced the successful development of an optimized mRNA manufacturing process.
02-11-2021
HERCULES, Calif.––Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been listed with the US Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD use...
21-10-2021
London, UK, 18 October 2021: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the release of the latest version of its laboratory automation software, labCONSOL™ 1.2. The new functionality included in the update further enhances the intuitive user experience to increase lab productivity and...
18-10-2021
Bishop’s Stortford, UK, and Portland, ME, USA, 12 October 2021: Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, today announced a partnership with RockStep Solutions (RockStep), a developer of software tools for managing data and operations for in...
12-10-2021
Beverly MA, US, 05 October 2021: seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing platform, today announced five appointments to its commercial team.
05-10-2021
Rome, IT, 04 October 2021: CrestOptics SpA, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the launch of DeepSIM, a super resolution module designed to enhance the imaging capabilities of confocal microscope systems. The DeepSIM module can be used with Crest’s X-light V3 spinning disk, or alternative...
04-10-2021
Uppsala, Sweden, 30 September 2021: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® AAV9 Titer Kit for rapid determination of physical titer in adeno-associated virus serotype 9 (AAV9) vector-based cell and gene therapy manufacturing.
30-09-2021
HERCULES, Calif.–September 30, 2021: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex™ Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens. The panels are for research use only (RUO).
30-09-2021
SANTA ANA, California: FUJIFILM Irvine Scientific, Inc. today announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility and equipment in anticipation of full operations starting in late 2021. The new facility will join manufacturing...
29-09-2021
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that a pre-clinical development milestone has been achieved in the multi-target therapeutics development partnership with LG Chem Life Sciences, the life sciences division of...
29-09-2021
Optibrium™, a developer of software for drug discovery, today announced the appointment of Professor Andy Black as non-executive Chair of its Board of Directors. Following the company’s recent investment from Kester Capital, the appointment will help to continue Optibrium’s strong commercial growth calling on Andy’s extensive experience in leading strategic expansion. This will include the...
21-09-2021
Highly accomplished technology CEO appointed to accelerate the company’s immense scale and capitalise on unprecedented momentum.
21-09-2021
York, UK: The European Laboratory Research & Innovation Group (ELRIG) UK today announced it will launch its equality, diversity, and inclusion (EDI) guiding principles at Drug Discovery 2021. The principles were developed with the support of Equality, Diversity and Inclusion in Science and Health (EDIS), a coalition of organisations working to improve EDI within the science and health...
21-09-2021
Pages
There are no events to display
22/11/2021
PR and Marketing Manager
As PR and Marketing Manager you will be part of the Zyme Communications (Zyme) team and will manage client accounts and...
Location: Cambridge
Salary Range:
Competitive
22/11/2021
PR and Marketing Executive
As PR and Marketing Executive you will be providing support across Zyme Communications (Zyme) clients. You will be part of...
Location: Cambridge
Salary Range:
Competitive
No Blog articles found
